Acute Acquired Concomitant Esotropia (AACE): Current Understanding, Emerging Mechanisms, and Novel Treatment Strategies
Introduction
Acute Acquired Concomitant Esotropia (AACE) is a relatively uncommon but increasingly recognized subtype of strabismus characterized by:
- Sudden onset esotropia
- Horizontal diplopia
- Concomitant ocular deviation (similar angle in all gaze positions)
- Absence of extraocular muscle palsy or major abduction deficits
- Often preserved binocular potential
Historically considered rare, AACE has become substantially more prevalent over the last decade, particularly among children, adolescents, and young adults. Multiple recent studies associate this rise with prolonged near viewing and excessive digital device use, especially smartphones and tablets. (PMC)
The condition has gained particular attention since the COVID-19 pandemic, during which lockdown-related increases in screen exposure coincided with a marked spike in incidence. (Springer Link)
Historical Background and Classification
The classical Burian–Miller classification divides AACE into three major subtypes:
1. Swan Type (Type I)
Occurs after disruption of binocular fusion, often due to:
- Monocular occlusion
- Visual deprivation
- Sudden loss of binocular input
2. Burian–Franceschetti Type (Type II)
Associated with:
- Minimal refractive error
- Psychological stress
- Sudden diplopia without obvious neurologic disease
3. Bielschowsky Type (Type III)
Traditionally linked to:
- Moderate or high myopia
- Excessive near work
- Divergence insufficiency mechanisms
More recent classifications increasingly recognize “digital-device associated AACE” as a distinct clinical phenotype. (Frontiers)
Epidemiology
Recent literature suggests:
- Increasing incidence worldwide
- Higher prevalence in East Asian populations
- Rising frequency in school-aged children and young adults
- Strong temporal association with COVID-era online learning and smartphone overuse
Several multicenter studies demonstrated a dramatic increase in cases beginning around 2020. (Springer Link)
Risk factors include:
- Prolonged near viewing
- Smartphone use at short working distances
- Myopia
- Reduced outdoor activity
- Psychological stress and fatigue
- Excessive accommodation-convergence load
Clinical Presentation
Typical symptoms include:
| Symptom | Description |
|---|---|
| Diplopia | Usually binocular horizontal diplopia |
| Sudden esotropia | Often noticed over days or weeks |
| Asthenopia | Eye strain and headaches |
| Distance deviation | Frequently larger at distance fixation |
| Preserved ocular motility | No true cranial nerve palsy |
| Loss of stereoacuity | Variable severity |
Many patients retain surprisingly good fusion potential if treated early.
Pathophysiology
The exact neural mechanism remains incompletely understood.
Current Leading Hypotheses
1. Excessive Near Work Hypothesis
The dominant current model proposes that sustained near fixation induces:
- Increased tonic convergence
- Medial rectus overactivation
- Adaptive shortening of convergence tone
- Breakdown of divergence fusional reserves
This mechanism resembles an acquired imbalance between convergence and divergence control systems. (PMC)
2. Neuroplastic Adaptation Hypothesis
Recent work suggests cortical and cerebellar plasticity may contribute:
- Persistent near fixation may recalibrate vergence networks
- Adaptive changes in binocular disparity processing
- Altered sensorimotor fusion stability
Potential structures involved:
- Midbrain supraoculomotor area
- Cerebellar vermis
- Frontal eye fields
- Parietal vergence networks
- Brainstem vergence generators
3. Myopic Mechanical Hypothesis
In highly myopic patients:
- Elongated globes alter extraocular muscle geometry
- Reduced divergence amplitudes emerge
- Mechanical and neural factors interact
This overlaps partly with divergence insufficiency esotropia.
Neurological Concerns and Neuroimaging
One of the major clinical questions is whether AACE reflects serious neurological disease.
Historically, acute esotropia has occasionally been associated with:
- Posterior fossa tumors
- Chiari malformation
- Hydrocephalus
- Increased intracranial pressure
- Demyelinating disease
However, modern evidence suggests that most contemporary AACE cases are benign and non-neurological. (OUCI)
Red Flags Requiring Neuroimaging
MRI should be strongly considered if patients exhibit:
- Nystagmus
- Headache
- Ataxia
- Papilledema
- Abduction deficits
- Neurological symptoms
- Incomitant deviation
- Altered consciousness
- Rapid progression
Diagnostic Workup
Essential Ophthalmic Evaluation
Orthoptic Assessment
- Prism cover testing
- Distance vs near deviation
- Fusional vergence amplitudes
- Stereoacuity testing
Cycloplegic Refraction
Important to exclude:
- Accommodative esotropia
- Hyperopic drivers
Ocular Motility Examination
Must confirm:
- Full abduction
- Absence of paralytic strabismus
Neuroimaging (when indicated)
MRI brain/orbits if atypical features are present.
Conventional Treatments
1. Reduction of Digital Device Use
Recent studies show partial improvement in some patients after:
- Restricting smartphone use
- Increasing working distance
- Limiting near fixation duration
However, effects are inconsistent once deviation becomes established. (Springer Link)
2. Prism Therapy
Base-out prisms may:
- Reduce diplopia
- Stabilize fusion
- Improve quality of life
- Delay surgery
Prisms are especially useful in:
- Small-angle AACE
- Fluctuating deviations
- Early-stage disease
3. Vision Therapy / Orthoptic Rehabilitation
Emerging evidence suggests benefit from:
- Divergence training
- Fusional vergence exercises
- Binocular therapy
- Stereopsis rehabilitation
Recent reports combining prisms and vision therapy demonstrated encouraging outcomes. (PLOS)
4. Strabismus Surgery
Currently remains the gold-standard definitive treatment.
Typical procedures include:
- Bilateral medial rectus recession
- Unilateral recession-resection procedures
Surgical outcomes are generally excellent:
- High motor alignment success
- Restoration of binocular single vision
- Good stereopsis recovery if treated early
Several studies report >80–90% alignment success. (PMC)
Novel and Emerging Treatments
1. Botulinum Toxin Injection
One of the most actively studied modern therapies is: Botulinum toxin type A injection into the medial rectus muscles.
Advantages
- Minimally invasive
- Office-based
- Faster recovery
- Avoids surgical scarring
- Useful in children and fluctuating cases
Recent studies report:
- Significant improvement in alignment
- Recovery of stereopsis
- Good patient satisfaction
- Comparable outcomes to surgery in selected patients
There is growing interest in early chemodenervation before chronic motor adaptation develops.
2. Vergence-Based Digital Therapeutics
An exciting emerging area involves:
- VR-based binocular therapy
- Computerized vergence rehabilitation
- Adaptive disparity training
- Eye-tracking-guided fusion exercises
These approaches attempt to:
- Restore divergence reserves
- Rebalance vergence control
- Promote cortical binocular plasticity
This field is still early but highly promising.
3. Personalized Surgical Planning Using Prism Adaptation
Recent studies suggest prism adaptation protocols may:
- Better predict surgical angle
- Reduce postoperative undercorrection
- Improve long-term alignment stability
4. AI and Eye-Tracking Approaches
Emerging research is exploring:
- AI-based ocular alignment analysis
- Home monitoring with smartphone cameras
- Quantitative vergence tracking
- Continuous binocular instability measurements
These tools may eventually allow:
- Earlier detection
- Longitudinal monitoring
- Precision treatment adjustment
Latest Research Trends
Digital Device–Associated AACE
The strongest recent trend is recognition of: “Smartphone-associated AACE”
Key observations:
- Very short viewing distances (<20 cm)
- Extended screen time
- High accommodative-convergence demand
- Reduced outdoor viewing
Multiple recent studies strongly support this association. (Lippincott Journals)
Quality of Life Research
Newer work emphasizes:
- Psychosocial burden
- Anxiety from diplopia
- Reduced reading performance
- Social discomfort
Adult AACE significantly reduces vision-related quality of life. (Springer Link)
Refinement of Classification
Modern researchers increasingly argue that traditional classification systems are inadequate because:
- Digital-device AACE differs mechanistically
- Some cases overlap divergence insufficiency
- Others show strong neuroplastic components
New fusion-based classification frameworks have recently been proposed. (Frontiers)
Future Directions
The future of AACE research likely includes:
1. Neurophysiology of Vergence Control
Better understanding:
- Cortical disparity processing
- Cerebellar adaptation
- Sensorimotor fusion breakdown
2. Digital Biomarkers
Continuous eye-tracking metrics may identify:
- Early binocular instability
- Preclinical vergence failure
3. Preventive Ophthalmology
Public health interventions may include:
- Limiting near screen time
- Increasing viewing distance
- Outdoor visual activity
- Pediatric screen hygiene guidelines
4. Precision Therapeutics
Combining:
- Botulinum toxin
- Binocular rehabilitation
- Personalized surgery
- AI-guided monitoring
may create individualized treatment pipelines.
Conclusion
AACE has evolved from a rare ophthalmologic curiosity into an increasingly important modern binocular vision disorder strongly associated with contemporary visual behavior and digital lifestyles.
Current evidence suggests:
- Most cases are benign and non-neurological
- Excessive near viewing is a major contributor
- Early diagnosis improves binocular recovery
- Surgical treatment remains highly effective
- Botulinum toxin and binocular rehabilitation are emerging alternatives
- Neuroplastic and sensorimotor mechanisms are increasingly recognized
The rapid rise in AACE prevalence may represent one of the clearest examples of how modern technological environments can reshape oculomotor and binocular visual systems.
Selected Key References
-
Nishikawa N, Sato M. Acute acquired concomitant esotropia: Current understanding of its etiological classification and treatment strategies. 2024. (PMC)
-
Guo S et al. Advances in the diagnosis and treatment of acute acquired concomitant esotropia. 2024. (Springer Link)
-
Wen W et al. Clinical practices on acute acquired concomitant esotropia. 2025. (ScienceDirect)
-
Zhang H et al. Botulinum toxin for acute acquired concomitant esotropia. 2025. (Springer Link)
-
Iimori H et al. Impact of prolonged digital device use on acquired concomitant esotropia. 2025. (Springer Link)
-
Sun A et al. Clinical characteristics and quality of life in adults with acute concomitant acquired esotropia. 2026.